Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis

Rheumatoid Arthritis

LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis

Clin Rheumatol.

Li J, Che N, Xu L, Zhang Q, Wang Q, Tan W, Zhang M

doi: 10.1007/s10067-018-4021-6.

Rheumatoid ArthritisSpinal Disorders

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Arthritis Res Ther.

Jarlborg M, Courvoisier DS, Lamacchia C, Martinez Prat L, Mahler M, Bentow C, Finckh A, Gabay C, Nissen MJ, physicians of the Swiss Clinical Quality Management (SCQM) registry.

doi: 10.1186/s13075-020-02190-3.

Psoriatic ArthritisRheumatoid Arthritis

Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission

Clin Exp Rheumatol.

Ramírez J, Iniciarte-Mundo J, Cuervo A, Ruiz-Esquide V, Hernández MV, Sanmartí R, Cañete JD

Rheumatoid Arthritis

Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY.

Arthritis Res Ther.

Boyapati A, Msihid J, Fiore S, van Adelsberg J, Graham NM, Hamilton JD

Rheumatoid Arthritis

Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial

J Rheumatol.

Hambardzumyan K, Bolce RJ, Wallman JK, van Vollenhoven RF, Saevarsdottir S

doi: 10.3899/jrheum.180537.

COMMENTED

Rheumatoid Arthritis

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort

★ 2 Recommended and commented by Dr Heino Prillwitz, Faculty Member

Arthritis Res Ther.

Lukas C, Mary J, Debandt M, Daïen C, Morel J, Cantagrel A, Fautrel B, Combe B

doi: 10.1186/s13075-019-2020-x.

Rheumatoid Arthritis

Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis

Clin Exp Immunol.

Dunaeva M, Blom J, Thurlings R, Pruijn GJM

doi: 10.1111/cei.13156.

Rheumatoid Arthritis

Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study

Arthritis Res Ther

Drobinski PJ, Bay-Jensen AC, Karsdal MA, Sardar S, Siebuhr AS

doi: 10.1186/s13075-020-02378-7

PsoriasisPsoriatic Arthritis

Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis

J Eur Acad Dermatol Venereol.

Pasquali L, Svedbom A, Srivastava A, Rosén E, Lindqvist U, Ståhle M, Pivarcsi A, Sonkoly E

doi: 10.1111/jdv.16203.

Related content

LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission

Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY.

Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort

Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis

Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study

Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis